Emerging Markets Clinical Trials Eastern Europe

Emerging Markets Clinical Trials Eastern Europe

$995.00

Use this study as a resource to design and prepare your company's clinical trials in Central and Eastern Europe. The report addresses, in detail, the cultural challenges in clinical trials and clinical development opportunities that these emerging markets provide. It provides detailed benchmark metrics for Russia, Poland, the Balkans, Bulgaria, Romania, Turkey and Ukraine, all in one place. Learn the advantages and challenges that each of these countries present.

  • Description
  • Additional information

REPORT HIGHLIGHTS

Emerging Markets Clinical Trials: Eastern Europe

  • Publication Date: November 2010
  • Pages: 187
  • Chapters: 3
  • Metrics: 400+
  • Charts/Graphics: 127
  • Profiles: 18

Section 1: Clinical Development Overview:

  • Key demographics (population/ethnic breakdowns, life expectancy statistics)
  • Key economic figures (GDP, labor force, distribution of family income)
  • Disease prevalence
  • Politics
  • Healthcare system
  • Pharmaceutical market (overall picture of market, leading local companies)

Clinical Development Strategy Charts focus on these points:

  • Percentage of budget saved by running a trial in this market
  • Percentage of time saved by running a trial in this market
  • Assigning clinical development responsibilities
Report Features

The report addresses, in detail, the challenges and clinical development opportunities that these emerging markets provide. It provides detailed benchmark metrics for Russia, Poland, the Balkans, Bulgaria, Romania, Turkey and Ukraine, all in one place. Learn the advantages and challenges that each of these countries present. IP issues can be daunting when working in an emerging market. This study shows you how to work with local partners to navigate culture and regulations, avoid the threat of corruption and protect your intellectual property.

Reason to Buy

Russia and Poland offer a distinct advantage as emerging markets clinical trials eastern Europe access to treatment-naive patients. Recruitment and retention are strong in these countries as well. This report will guide your decision-making process as you determine how to run a trial in a Central or Eastern European nation. Learn about the other advantages that the central and eastern European countries offer to clinical development teams.

Target Audience

Executives, directors, and managers involved in the following areas should consider purchasing this report:
– Clinical development
– Site/Trial Management
– Patient Recruitment
– Strategic planning groups
– Contract Research Organizations (CROs)
– Strategic Planning

Chapter Example

Poland has a wealth of capable doctors and investigators. Medical personnel are hungry for knowledge and eager to participate in clinical trials — both reasons why the available knowledge base received a high score of 7.7 from survey respondents. Many of the principal investigators at the top research centers attend international conferences and are up to date on the latest treatments, making them comparable to investigators in Western Europe.
Nevertheless, in Poland the newest treatments are not always made available to patients. Physicians often jump at the chance to participate in clinical studies that can offer their patients access to cutting-edge treatments.A majority of the clinical research associates in Poland were originally doctors. They are extremely knowledgeable and communicate very well with principal investigators and study coordinators alike.One executive from a global CRO notice a healthy camaraderie and competition between principal investigators, who are often willing to communicate best practices across different sites. Many investigators, especially within the same therapeutic areas, have been working side by side on clinical trials for 10 years or longer.